Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration (Wet AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00590694
What this trial is testing

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

Who this might be right for
Age-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular Degeneration+1 more
Pacific Eye Associates 15
Post-approval studies (Phase 4)Study completedNCT01775124
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 332
Not applicableStudy completedNCT02289924
What this trial is testing

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy

Who this might be right for
Wet Macular Degeneration
Bayer 912
Not applicableStudy completedNCT03470103
What this trial is testing

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

Who this might be right for
Macular Degeneration
Bayer 643
Large-scale testing (Phase 3)Ended earlyNCT00065728
What this trial is testing

Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

Who this might be right for
Macular Degeneration
Alcon Research 111
Testing effectiveness (Phase 2)UnknownNCT00032396
What this trial is testing

Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Control Delivery Systems
Early research (Phase 1)UnknownNCT01217762
What this trial is testing

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationWet Age-Related Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT04832724
What this trial is testing

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular DegenerationWet Age-related Macular Degeneration
AbbVie 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04514653
What this trial is testing

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AbbVie 146
Large-scale testing (Phase 3)Study completedNCT03668054
What this trial is testing

Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)

Who this might be right for
Age-Related Macular Degeneration
Laboratorio Elea Phoenix S.A. 22
Early research (Phase 1)Study completedNCT03585556
What this trial is testing

AAVCAGsCD59 for the Treatment of Wet AMD

Who this might be right for
Wet Age-related Macular Degeneration
Janssen Research & Development, LLC 25
Early research (Phase 1)Study completedNCT00503022
What this trial is testing

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis 20
Early research (Phase 1)UnknownNCT03675880
What this trial is testing

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

Who this might be right for
AMD
Lee's Pharmaceutical Limited 24
Testing effectiveness (Phase 2)Study completedNCT03066258
What this trial is testing

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Who this might be right for
Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
REGENXBIO Inc. 42
Not applicableStudy completedNCT04982484
What this trial is testing

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab Treatment

Who this might be right for
OphthalmopathyWet Macular Degeneration
Centre Hospitalier Régional Metz-Thionville 50
Post-approval studies (Phase 4)UnknownNCT00813891
What this trial is testing

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationVisual Acuity
McGill University Health Centre/Research Institute of the McGill University Health Centre 180
Testing effectiveness (Phase 2)Study completedNCT03927690
What this trial is testing

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 91
Post-approval studies (Phase 4)Study completedNCT02441816
What this trial is testing

VITAL - Individualising Therapy for Neovascular AMD With Aflibercept

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 50
Not applicableActive Not RecruitingNCT03102138
What this trial is testing

Retinal Pigment Epithelium Safety Study for Patients in B4711001

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 10
Not applicableStudy completedNCT01269151
What this trial is testing

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD

Who this might be right for
Age-Related Macular DegenerationRetinal Function
University of Luebeck 20
Next Page